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4. Discussion
  Until now, studies on microRNA-126 mainly focuse on aspects of 
effects that it was a tumor suppressor gene[8]. In recent years, the 
roles of microRNA-126 in inflammation aspects also attract people’s 
attention, but its detailed mechanism is still not clear[9]. In addition, 
in development process of human lung, heart and kidney, the roles of 
microRNA-126 also need further investigation. 
  At present, people’s attention focuses on the functions of microRNA 
in tumor occurrence and development, but molecular mechanisms 
how microRNAs playing their roles are still not understood, and 
there are many conceptive and experimental problems. Up to 
2014, Sanger miRBase database (miRBase 21 released) has 28645 
approved microRNAs, in which only dozens of microRNAs have 
been analyzed in lung cancer occurrence and development up to 
now. It’s a new arduous task to seek other lung cancer-associated 
microRNAs, identify its downstream target molecule and determine 
the mechanisms of microRNAs playing roles in lung cancer 
occurrence and development.
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  The 2014 Western Ebolavirus infectionis the serious emerging 
disease at present[1-3]. This disease result in high fatality and 
rapidly widespread in Africa, hence, it becomes the present concern 
for medical society[1-3]. The knowledge on clinical presentation 
on this new Ebola virus infection is extremely limited. It is known 
only that Ebola virus infection can present as an acute febrile illness 
with hemorrhagic complication. Here, the authors try to summarize 
on the magnitude of “fever” as presentation in the 2014 Western 
Ebolavirus infection. Based on available data from 15 confirmed 
casesreported from Guinea[1-4], not all cases showed fever at 
presentation. The rate of afebrile case at presentation is equal to 
9.3%. Hence, it should be noted that the afebrile 014 Western 
Ebolavirus infection is possible and this challenge the immigration 
system that mainly use fever screening as tool for screening traveler 
from outbreak area.
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